Cargando…
Potential Stereoselective Binding of Trans-(±)-Kusunokinin and Cis-(±)-Kusunokinin Isomers to CSF1R
Breast cancer cell proliferation and migration are inhibited by naturally extracted trans-(−)-kusunokinin. However, three additional enantiomers of kusunokinin have yet to be investigated: trans-(+)-kusunokinin, cis-(−)-isomer and cis-(+)-isomer. According to the results of molecular docking studies...
Autores principales: | Chompunud Na Ayudhya, Chompunud, Graidist, Potchanapond, Tipmanee, Varomyalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268608/ https://www.ncbi.nlm.nih.gov/pubmed/35807438 http://dx.doi.org/10.3390/molecules27134194 |
Ejemplares similares
-
Trans-(−)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?
por: Rattanaburee, Thidarath, et al.
Publicado: (2021) -
Trans-(±)-TTPG-B Attenuates Cell Cycle Progression and Inhibits Cell Proliferation on Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2023) -
Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells
por: Mad-Adam, Nadeeya, et al.
Publicado: (2022) -
(−)-Kusunokinin as a Potential Aldose Reductase
Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2020) -
Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2022)